Pancytopenia Completed Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Pancytopenias

IndicationStatusPhase
DBCOND0001569 (Pancytopenia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01193283Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic AnemiaTreatment
NCT01187017A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic AnemiaTreatment